{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":11,"sponsored":0,"items":[{"id":"n_bphj2lwtw6gcbyewlsqa","seq":1591421,"kind":"article","title":"Are GLP-1 users eating out less, or just ordering less?","url":"https://abc17news.com/stacker-food-drink/2026/10/03/are-glp-1-users-eating-out-less-or-just-ordering-less","published":"2026-10-03T16:39:00Z","seen":"2026-10-03T22:07:11Z","lang":"en","source":{"id":"abc17news.com","name":"abc17news.com","domain":"abc17news.com","outlet":{"wikidata":"Q6333614","name":"KMIZ","type":"broadcaster","country":"US","designations":["television station"]}},"via":"gdelt-gkg-english","topics":["economy"],"authors":["Stacker"],"entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_kxuizfhwtihqzref5mta","category":"health","category_p":0.42,"category2":"economy-business","sentiment":"neutral","tone":-0.03,"political":0.08},{"id":"n_d7blrn46tbqfsljynl6q","seq":1516471,"kind":"article","title":"GLP-1 entra em nova fase para farmácias, com preço menor e disputa por volume, diz XP","title_en":"GLP-1 enters a new phase for pharmacies, with lower price and competition for volume, says XP","url":"https://www.infomoney.com.br/mercados/glp-1-entra-em-nova-fase-para-farmacias-com-preco-menor-e-disputa-por-volume-diz-xp","summary":"Crescimento da concorrência pode reduzir preços The post GLP-1 entra em nova fase para farmácias, com preço menor e disputa por volume, diz XP appeared first on InfoMoney .","published":"2026-10-03T10:00:00Z","seen":"2026-10-03T10:27:15Z","lang":"pt","country":"BR","source":{"id":"kite-infomoney-com-br-09b7ce","name":"infomoney.com.br","domain":"infomoney.com.br","outlet":{"wikidata":"Q121141771","name":"InfoMoney","type":"newspaper","country":"BR","designations":["newspaper","online newspaper"]}},"via":"kite-infomoney-com-br-09b7ce","topics":["mercados","canetas emagrecedoras","glp-1","ozivy","semaglutida"],"authors":["Erick Souza"],"entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_d7blrn46tbqfsljynl6q","category":"economy-business","category_p":0.86,"sentiment":"neutral","tone":0.18,"political":0.08},{"id":"n_mk2huoybx5ase3a5t3xa","seq":1446029,"kind":"article","title":"Critics say GLP-1 coverage shift raises equity issues","url":"https://www.lowellsun.com/2026/10/02/critics-say-glp-1-coverage-shift-raises-equity-issues","published":"2026-10-02T18:05:00Z","seen":"2026-10-02T23:12:37Z","lang":"en","source":{"id":"lowellsun.com","name":"lowellsun.com","domain":"lowellsun.com","outlet":{"wikidata":"Q2077538","name":"The Sun","type":"newspaper","designations":["newspaper","website"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Alison Kuznitz"],"entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_2ih6glyptc33nwgtsehq","category":"politics","category_p":0.42,"category2":"economy-business","sentiment":"negative","tone":-0.32,"political":0.66},{"id":"n_i6vkkfzuogez4px7t23a","seq":1272963,"kind":"article","title":"‘비만 치료 혁명’ GLP-1, 노벨의학상 품을까⋯5일 수상자 발표","title_en":"'Obesity treatment revolution' GLP-1 may win Nobel Prize in Medicine... Winner to be announced on the 5th","url":"https://kormedi.com/2877709","summary":"전 세계 비만치료제 시장을 뒤흔든 위고비·마운자로의 출발점인 ‘글루카곤 유사 펩타이드-1(GLP-1)’ 연구가 올해 노벨 생리의학상의 주인공이 될지 관심이 쏠린다.… The post ‘비만 치료 혁명’ GLP-1, 노벨의학상 품을까⋯5일 수상자 발표 appeared first on 코메디닷컴 .","published":"2026-10-02T04:57:53Z","seen":"2026-10-02T05:47:11Z","lang":"ko","source":{"id":"kite-kormedi-com-1cc5b2","name":"kormedi.com","domain":"kormedi.com","outlet":{"wikidata":"Q24858392","name":"Kormedi.com","type":"newspaper","country":"KR","designations":["online newspaper"]}},"via":"kite-kormedi-com-1cc5b2","topics":["medicine","의료"],"authors":["서윤경 기자"],"entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"image":"https://kormedi.com/wp-content/uploads/2026/10/gettyimages-2271138344-edited.jpg","story":"st_i6vkkfzuogez4px7t23a","category":"health","category_p":0.59,"sentiment":"neutral","tone":0.21,"political":0.15},{"id":"n_f2wxrvrfkfsjxdvuym4q","seq":1257952,"kind":"article","title":"삼천당제약, CPHI 첫 단독부스…경구용 인슐린·GLP-1 협력 모색","title_en":"Samcheondang Pharmaceuticals, CPHI's first solo booth... Seeking cooperation for oral insulin and GLP-1","url":"https://www.etnews.com/20261002000125","summary":"삼천당제약이 글로벌 제약산업 전시회 'CPHI 2026'에 처음으로 단독부스를 마련하고 해외 협력 확대에 나선다. 점안제와 바이오시밀러 수출 품목을 소개하고 경구용 인슐린 등 개발 파이프라인의 기술이전과 공동개발 기회를 모색한다. 삼천당제약은 오는 6일부터 8일까지 이탈리아 밀라노 피에라 밀라노에서 열리는 CPHI 2026에 참가한다고 2일 밝혔다. CPHI는 원료의약품부터 완제의약품, 바이오의약품, 위탁개발생산(CDMO), 약물전달기술까지 제","published":"2026-10-02T03:14:56Z","seen":"2026-10-02T03:44:37Z","lang":"ko","country":"KR","source":{"id":"kite-etnews-com-fc329c","name":"etnews.com","domain":"rss.etnews.com"},"via":"kite-etnews-com-fc329c","authors":["author"],"entities":[{"id":"Q140367758","name":"Centre For Population Health Initiatives","type":"event"},{"id":"Q21198761","name":"Oral Insulin","type":"other"},{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_smck2ghzhazwihjlqfia","category":"health","category_p":0.55,"category2":"economy-business","sentiment":"neutral","tone":0.12,"political":0.05},{"id":"n_hirao5uzbbg5nmlqbjnq","seq":1166589,"kind":"article","title":"Dad claims he went suddenly, permanently blind from Ozempic — in one of hundreds of lawsuits against GLP-1 makers","url":"https://freerepublic.com/focus/f-chat/4397523/posts","published":"2026-10-01T14:45:00Z","seen":"2026-10-01T15:38:39Z","lang":"en","source":{"id":"freerepublic.com","name":"freerepublic.com","domain":"freerepublic.com"},"via":"gdelt-gkg-english","topics":["economy"],"entities":[{"id":"Q47521958","name":"Ozempic","type":"other"},{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_cskq2pjnylkqkrjhynja","category":"crime-law","category_p":0.41,"sentiment":"negative","tone":-0.77,"political":0.06},{"id":"n_zuwzqszgytqhsalhbzga","seq":889884,"kind":"article","title":"GLP-1 use spreads beyond obesity treatment","url":"https://www.bakeryandsnacks.com/Article/2026/09/30/glp-1-use-spreads-beyond-obesity-treatment","published":"2026-09-30T08:01:00Z","seen":"2026-09-30T11:25:45Z","lang":"en","source":{"id":"bakeryandsnacks.com","name":"bakeryandsnacks.com","domain":"bakeryandsnacks.com","outlet":{"wikidata":"Q140944515","name":"Bakery&Snacks","type":"website","designations":["publication","website"]}},"via":"gdelt-gkg-english","topics":["economy","health","education"],"entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_uzpqjsd7fdks7wvldzjq","category":"health","category_p":0.91,"sentiment":"negative","tone":-0.0,"political":0.08},{"id":"n_ngjsvivww6u2ckdye77q","seq":853112,"kind":"article","title":"GLP-1 σε εφήβους: Οι διατροφικές ανεπάρκειες που καταγράφηκαν","title_en":"GLP-1 in adolescents: The nutritional deficiencies recorded","url":"https://www.newsit.gr/ygeia/glp-1-se-efivous-oi-diatrofikes-aneparkeies-pou-katagrafikan/4786615","summary":"Οι αγωνιστές υποδοχέα GLP-1 (GLP-1 receptor agonists) -φάρμακα που μειώνουν την όρεξη, επιβραδύνουν τη γαστρική κένωση και αυξάνουν το αίσθημα κορεσμού- χρησιμοποιούνται ολοένα περισσότερο σε ... To άρθρο GLP-1 σε εφήβους: Οι διατροφικές ανεπάρκειες που καταγράφηκαν δημοσιεύτηκε στο NewsIT .","published":"2026-09-30T07:58:24Z","seen":"2026-09-30T08:08:11Z","lang":"el","country":"GR","source":{"id":"kite-newsit-gr-f7a724","name":"newsit.gr","domain":"newsit.gr"},"via":"kite-newsit-gr-f7a724","topics":["υγεία","διατροφη","εφηβοι","φαρμακα"],"authors":["Γιάννης Χατζηδοπαυλάκης"],"entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_ngjsvivww6u2ckdye77q","category":"health","category_p":0.79,"sentiment":"negative","tone":-0.62,"political":0.01},{"id":"n_2wan4lw7dwsmzz2xr6ea","seq":628018,"kind":"article","title":"ANJAC HEALTH & BEAUTY LAUNCHES A DEDICATED OFFERING TO SUPPORT PATIENTS ON GLP-1 TREATMENTS","url":"https://www.manilatimes.net/2026/09/29/tmt-newswire/globenewswire/anjac-health-beauty-launches-a-dedicated-offering-to-support-patients-on-glp-1-treatments/2434800","published":"2026-09-29T09:07:00Z","seen":"2026-09-29T09:25:18Z","lang":"en","source":{"id":"manilatimes.net","name":"manilatimes.net","domain":"manilatimes.net","outlet":{"wikidata":"Q1573100","name":"The Manila Times","type":"magazine","country":"PH","designations":["organization","periodical"]}},"via":"gdelt-gkg-english","topics":["health"],"entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_o7a72onm2di5rskrf23q","category":"health","category_p":0.86,"sentiment":"positive","tone":0.71,"political":0.05},{"id":"n_75sk77gvbdcfo6tlgn2q","seq":533559,"kind":"article","title":"Chobani takes on Bega in flavoured milk market as demand for high-protein foods grows amid GLP-1 wave","url":"https://www.afr.com/companies/retail/chobani-challenges-bega-with-push-into-flavoured-milk-market-20260929-p610ym","published":"2026-09-28T19:00:00Z","seen":"2026-09-28T22:21:24Z","lang":"en","source":{"id":"afr.com","name":"afr.com","domain":"afr.com","outlet":{"wikidata":"Q1809545","name":"The Australian Financial Review","type":"newspaper","designations":["daily newspaper"]}},"via":"gdelt-gkg-english","topics":["economy"],"authors":["Simon Evans"],"entities":[{"id":"Q5103456","name":"Chobani","type":"org"},{"id":"Q5355102","name":"Bega","type":"org"},{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"}],"story":"st_75sk77gvbdcfo6tlgn2q","category":"economy-business","category_p":0.6,"sentiment":"positive","tone":0.24,"political":0.05},{"id":"n_f5pbuwykxx3e65cgtz3q","seq":334388,"kind":"article","title":"GLP-1 drugs may help sleep apnea, but CPAP remains best treatment: Study","url":"https://www.krqe.com/news/national/glp-1-drugs-may-help-sleep-apnea-but-cpap-remains-best-treatment-study","summary":"Weight-loss drugs may help reduce sleep apnea symptoms, but experts say they still can't match the effectiveness of a CPAP machine.","published":"2026-09-28T02:45:28Z","seen":"2026-09-28T03:40:31Z","lang":"en","country":"US","source":{"id":"kite-krqe-com-a20e88","name":"krqe.com","domain":"krqe.com","outlet":{"wikidata":"Q109973289","name":"KBIM-TV","type":"broadcaster","country":"US","designations":["television station"]}},"via":"kite-krqe-com-a20e88","topics":["new-mexico","latest news","national","top stories"],"authors":["Rob Taub"],"entities":[{"id":"Q424611","name":"glucagon-like peptide-1","type":"other"},{"id":"Q18042093","name":"CPAP","type":"other"}],"image":"https://www.krqe.com/wp-content/uploads/sites/12/2026/09/GettyImages-1253052589-e1790467391980.jpg?w=900","story":"st_ntn56kysw3mnklz64xiq","category":"health","category_p":0.87,"sentiment":"neutral","tone":0.09,"political":0.02}]}